PKTXProtoKinetix, Inc.

About ProtoKinetix, Inc. (PKTX)

ProtoKinetix, Inc. (PKTX) is a Biotechnology company headquartered in Dalton, OH, United States whose shares trade over-the-counter on the Pink tier.

ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever.

Products and services

ProtoKinetix is a clinical-stage biomedical research and development company. AAGP®, our patented anti-aging glycopeptide, is aimed at keeping more cells alive longer.

PKTX key facts

Ticker symbol

PKTX

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Dalton, OH, United States

Country of incorporation

US

Year of incorporation

1999

Estimated market cap

$4.95M (as of Apr 11, 2025)

Shares outstanding

380,580,152

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

ProtoKinetix, Inc. leadership

• Clarence E. Smith — CEO, President
• Michael Guzzetta — CFO
• Grant Young — Consultant

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with P